HCGstockHealthcare Global Enterprises Ltd
₹628.5
▲+0.42%
Open
₹623.55
High
₹639.65
Low
₹623.55
Volume
76.7K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹193.42026-06-18 · ₹623.1
Instrument details
- MB Code
- MBEQU5168
- Type
- stock
- ISIN
- INE075I01017
- BSE
- 539787
- Industry
- Healthcare Services
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 652.33 Cr
- Net profit
- 4.04 Cr
- EPS
- 0.15
- YoY revenue
- +11.48%
Price returns
Historical performance
- 1 day
- -0.37%
- 1 month
- -3.65%
- 3 months
- +14.75%
- 1 year
- +16.25%
- 3 years
- +98.81%
- 5 years
- +226.03%
Technicals
Indicator consensus
Bullish
17
Neutral
4
Bearish
25
RSI 30.92(Neutral)
Company documents
Annual reports, concalls, presentations
Annual reports
18Concall transcripts
28Investor presentations
86Corporate announcements
345Corporate timeline
Price chart events · 1 year
Rights
2026-03-02
{"rightRatio":"1:17"}
Earnings
2026-05-19
{"actualRevenue":6502900000,"estimateRevenue":6765000000,"revenueSurprise":-262100000,"revenueSurprisePercent":-3.874353288987435,"actualEPS":2.36,"estimateEPS":1.5257666,"surprise":0.8342334,"surprisePercent":54.67634433733181}
Earnings
2025-11-12
{"actualRevenue":6451600000,"estimateRevenue":6600000000,"revenueSurprise":-148400000,"revenueSurprisePercent":-2.248484848484849,"actualEPS":1.15287,"estimateEPS":1.485609,"surprise":-0.3327390000000001,"surprisePercent":-22.39748143690568}
Earnings
2025-08-01
{"actualRevenue":6118000000,"estimateRevenue":6654000000,"revenueSurprise":-536000000,"revenueSurprisePercent":-8.055305079651337,"actualEPS":0.33791,"estimateEPS":0.702657,"surprise":-0.364747,"surprisePercent":-51.90967997187818}
Earnings
2026-02-05
{"actualRevenue":6311800000,"estimateRevenue":6438000000,"revenueSurprise":-126200000,"revenueSurprisePercent":-1.960236098167133,"actualEPS":-1.58023,"estimateEPS":0.7428045000000001,"surprise":-2.3230345,"surprisePercent":-312.7383450154112}
News
2026-05-22
{"description":"HealthCare Global reiterated 15% FY27 revenue growth and 100 bps yearly EBITDA margin expansion, citing 200-bed additions, Kenya growth, and the ₹37 crore sale of Milann to fund expansion.","url":"https://www.cnbctv18.com/market/earnings/healthcare-global-enterprises-targets-200-bed-expansion-eyes-kenya-tier-2-city-hubs-for-next-growth-wave-q4-earnings-results-boardroom-19911583.htm","sentiment":"Positive","domain":"CNBCTV18"}